Cargando…

Whole Genome Analysis and Prognostic Model Construction Based on Alternative Splicing Events in Endometrial Cancer

OBJECTIVES: A growing body of evidence has shown that aberrant alternative splicing (AS) is closely related to the occurrence and development of cancer. However, prior studies mainly have concentrated on a few genes that exhibit aberrant AS. This study aimed to determine AS events through whole geno...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Caixia, Zheng, Mingjun, Wang, Shuang, Nie, Xin, Guo, Qian, Gao, Lingling, Li, Xiao, Qi, Yue, Liu, Juanjuan, Lin, Bei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6634061/ https://www.ncbi.nlm.nih.gov/pubmed/31355251 http://dx.doi.org/10.1155/2019/2686875

Ejemplares similares

Overexpression of TMEFF1 in Endometrial Carcinoma and the Mechanism Underlying its Promotion of Malignant Behavior in Cancer Cells
por: Nie, Xin, et al.
Publicado: (2021)

Combining Bioinformatics and Experiments to Identify and Verify Key Genes with Prognostic Values in Endometrial Carcinoma
por: Zhang, Wenchao, et al.
Publicado: (2020)

Prognostic Potential of Alternative Splicing Markers in Endometrial Cancer
por: Wang, Qian, et al.
Publicado: (2019)

Alternative splicing events are prognostic in hepatocellular carcinoma
por: Chen, Qi-Feng, et al.
Publicado: (2019)

Identification of prognostic alternative splicing events in sarcoma
por: Li, Hongshuai, et al.
Publicado: (2021)

Estrogen/estrogen receptor promotes the proliferation of endometrial carcinoma cells by enhancing hMOF expression
por: Qi, Yue, et al.
Publicado: (2020)

Construction of prognostic predictor by comprehensive analyzing alternative splicing events for colon adenocarcinoma
por: Qu, Yaqi, et al.
Publicado: (2020)

Alternative Splicing Events and Splicing Factors Are Prognostic in Adrenocortical Carcinoma
por: Lv, Jian, et al.
Publicado: (2020)

Comprehensive Analysis of Prognostic Alternative Splicing Signatures in Endometrial Cancer
por: Chen, Peigen, et al.
Publicado: (2020)

Identification of Tumor Microenvironment-Related Alternative Splicing Events to Predict the Prognosis of Endometrial Cancer
por: Liu, Xuan, et al.
Publicado: (2021)

Characterization of alternative splicing events and prognostic signatures in breast cancer
por: Han, Pihua, et al.
Publicado: (2021)

Prognostic risk assessment model for alternative splicing events and splicing factors in malignant pleural mesothelioma
por: Jiang, Yue, et al.
Publicado: (2022)

Construction of a model to predict the prognosis of patients with cholangiocarcinoma using alternative splicing events
por: Wu, Hua-Yu, et al.
Publicado: (2019)

Prognostic significance of survival-associated alternative splicing events in gastric cancer
por: Zhang, Shichao, et al.
Publicado: (2020)

Construction of novel mRNA-miRNA-lncRNA regulatory networks associated with prognosis of ovarian cancer
por: Gao, Lingling, et al.
Publicado: (2020)

Systematic profiling of alternative splicing signature reveals prognostic predictor for cervical cancer
por: Hu, Yue-Xin, et al.
Publicado: (2019)

Prognostic alternative splicing events related splicing factors define the tumor microenvironment and pharmacogenomic landscape in lung adenocarcinoma
por: Liu, Jichang, et al.
Publicado: (2022)

An interactive network of alternative splicing events with prognostic value in geriatric lung adenocarcinoma via the regulation of splicing factors
por: Wang, Yidi, et al.
Publicado: (2020)

Identification of long noncoding RNA RP11-89K21.1 and RP11-357H14.17 as prognostic signature of endometrial carcinoma via integrated bioinformatics analysis
por: Gao, Lingling, et al.
Publicado: (2020)

Alternative Splicing Events as Indicators for the Prognosis of Uveal Melanoma
por: Wan, Qi, et al.
Publicado: (2020)

Comprehensive Analysis of Splicing Factor and Alternative Splicing Event to Construct Subtype-Specific Prognosis-Predicting Models for Breast Cancer
por: Zhang, He, et al.
Publicado: (2021)

Prognostic Signatures of Alternative Splicing Events in Esophageal Carcinoma Based on TCGA Splice-Seq Data
por: Ye, Ping, et al.
Publicado: (2021)

Survival-Associated Alternative Splicing Events and Prognostic Signatures in Pancreatic Cancer
por: Xu, Lichao, et al.
Publicado: (2020)

Classification of glioma based on prognostic alternative splicing
por: Li, Yaomin, et al.
Publicado: (2019)

Characterization and prognostic significance of alternative splicing events in lower‐grade diffuse gliomas
por: Zhao, Zheng, et al.
Publicado: (2020)

Identification of tumour immune microenvironment-related alternative splicing events for the prognostication of pancreatic adenocarcinoma
por: Chen, Bo, et al.
Publicado: (2021)

Comprehensive characterization of 11 prognostic alternative splicing events in ovarian cancer interacted with the immune microenvironment
por: Yue, Congbo, et al.
Publicado: (2022)

Identification and Validation of a Prognostic Immune-Related Alternative Splicing Events Signature for Glioma
por: Wang, Minjie, et al.
Publicado: (2021)

Identification and clinical validation of NUSAP1 as a novel prognostic biomarker in ovarian cancer
por: Gou, Rui, et al.
Publicado: (2022)

Prognostic role of alternative splicing events in head and neck squamous cell carcinoma
por: Ding, Yanni, et al.
Publicado: (2020)

Identification of prognostic alternative splicing events related to the immune microenvironment of hepatocellular carcinoma
por: Yu, Shanshan, et al.
Publicado: (2021)

Screening Gene Expression-Related Alternative Splicing Event Signature for Colon Cancer Prognostic Prediction
por: Xu, Jie, et al.
Publicado: (2022)

Systematic Profiling of Alternative Splicing Events in Ovarian Cancer
por: Liu, Jia, et al.
Publicado: (2021)

Development of a seven-gene tumor immune microenvironment prognostic signature for high-risk grade III endometrial cancer
por: Zheng, Mingjun, et al.
Publicado: (2021)

Profiling of prognostic alternative splicing in melanoma
por: Ma, Fu-Chao, et al.
Publicado: (2019)

Prognostic Value and Potential Role of Alternative mRNA Splicing Events in Cervical Cancer
por: Shao, Xiang-yang, et al.
Publicado: (2020)

The Roles of Alternative Splicing in Tumor-immune Cell Interactions
por: Wang, Yue, et al.
Publicado: (2020)

Construction of the prognostic signature of alternative splicing revealed the prognostic predictor and immune microenvironment in head and neck squamous cell carcinoma
por: Ye, Fan, et al.
Publicado: (2022)

Prognostic alternative splicing regulatory network of RBM25 in hepatocellular carcinoma
por: Zhang, Yong-Fa, et al.
Publicado: (2021)

Impacts of Alternative Splicing Events on the Differentiation of Adipocytes
por: Lin, Jung-Chun
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_o8mokvr71bm3ba4emcafgirrsa